Good participatory practice : guidelines for biomedical HIV prevention trials 2011
2011
Files
Details
SymbolUNAIDS/JC1853
TitleGood participatory practice : guidelines for biomedical HIV prevention trials 2011
AccessEnglish: JC1853_GPP_Guidelines_2011_en_0 - PDF ; Español: JC1853_GPP_Guidelines_2011_es_0 - PDF ; Français: JC1853_GPP_Guidelines_2011_fr_0 - PDF ; Русский: JC1853_GPP_Guidelines_2011_ru_0 - PDF ; العربية: Good_Participatory_Practice_guidelines_Arabic_June_2011 - PDF ; 中文: GPP_Guidelines,_2nd_edition_(Chinese) - PDF ;
Summary
The good participatory practice (GPP) guidelines provide trial funders, sponsors, and implementers with systematic guidance on how to effectively engage with stakeholders in the design and conduct of biomedical HIV prevention trials. In the GPP guidelines, “design and conduct of biomedical HIV prevention trials” refers to activities required for the development, planning, implementation, and conclusion of a trial, including dissemination of trial results.
1. The importance of good participatory practice -- 2. The importance of good participatory practice -- 3. Good participatory practices in biomedical HIV prevention trials : Introduction to good participatory practices -- Annex 1. Acronyms and abbreviations -- Annex 2. Glossary -- Annex 3. Additional guidance.
1. The importance of good participatory practice -- 2. The importance of good participatory practice -- 3. Good participatory practices in biomedical HIV prevention trials : Introduction to good participatory practices -- Annex 1. Acronyms and abbreviations -- Annex 2. Glossary -- Annex 3. Additional guidance.
DateGeneva : Joint United Nations Programme on HIV/AIDS (UNAIDS), June 2011
Description
84 p. : graphs, tables
Notes
Includes bibliographical references (p. 82-84).